Rubric Capital Management (New York)’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,600,000
Closed -$26.3M 106
2022
Q4
$26.3M Hold
3,600,000
1.15% 28
2022
Q3
$24.9M Hold
3,600,000
1.25% 26
2022
Q2
$25.2M Hold
3,600,000
1.32% 24
2022
Q1
$29.8M Buy
3,600,000
+55,532
+2% +$501K 1.08% 27
2021
Q4
$38.3M Buy
3,544,468
+287,463
+9% +$3.1M 1.81% 23
2021
Q3
$39.2M Buy
+3,257,005
New +$36.8M 1.1% 21

Other funds holding AMYT

Rubric Capital Management (New York)'s AMYT Position: Q1 2023 in Review

Rubric Capital Management (New York) sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 3,600,000 shares — an estimated $26.3M sold.

Rubric Capital Management (New York) first reported a position in AMYT in Q3 2021 and held it in 6 quarters. The position peaked at $39.2M in Q3 2021. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.

  • Rubric Capital Management (New York) reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Rubric Capital Management (New York) sold 3,600,000 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $26.3M.
  • Rubric Capital Management (New York) first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2021 and held it in 6 quarters.
  • Rubric Capital Management (New York)'s Amryt Pharma plc American Depositary Shares position peaked at $39.2M in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2023, filed 12 May 2023.